Dogwood Therapeutics
DWTX
14 hedge funds and large institutions have $5.06M invested in Dogwood Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 5 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
56% more funds holding
Funds holding: 9 → 14 (+5)
11% more capital invested
Capital invested by funds: $4.55M → $5.06M (+$510K)
2.86% more ownership
Funds ownership: 7.74% → 10.6% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$1.06M |
| 2 |
Two Sigma Investments
New York
|
+$747K |
| 3 |
Two Sigma Advisers
New York
|
+$258K |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
+$194K |
| 5 |
CA
Cetera Advisors
Denver,
Colorado
|
+$164K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$715K |
| 2 |
VF
Virtu Financial
New York
|
-$264K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$25K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$7K |
| 5 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
-$4K |
DWTX Hedge Fund Activity: Q1 2021 in Review
14 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q1 2021, worth a combined $5.06M — up 11% from $4.55M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DWTX positions and 5 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Masters Capital Management, adding an estimated $1.06M. The largest seller was Jane Street, exiting entirely with an estimated $715K sold.
- 14 institutional investors held Dogwood Therapeutics (DWTX) as of Q1 2021, up from 9 in Q4 2020.
- Funds reported $5.06M of Dogwood Therapeutics stock for Q1 2021, up 11% quarter-over-quarter.
- 10 funds opened new Dogwood Therapeutics positions in Q1 2021 and 5 closed out, a net change of +5 holders.
- The largest Dogwood Therapeutics buyer in Q1 2021 was Masters Capital Management, an estimated $1.06M added.
- The largest Dogwood Therapeutics seller in Q1 2021 was Jane Street, an estimated $715K sold.
Based on aggregated 13F filings for Q1 2021.